Saving changes...

Done

Error

METFORMIN Volume 5 issue 8 (ODO001/009/11/2017

METFORMIN Volume 5 issue 8 (ODO001/009/11/2017

METFORMIN Volume 5 issue 8 (ODO001/009/11/2017

Dr Nina Kriel
Dr Nina Kriel
on behalf of Synapse Optometry

FREE
FREE
FREE

FREE
FREE
FREE

null FREE
FREE
FREE
null FREE
FREE
FREE
Normal Price: FREE FREE

Review:

Launch date: 22 Dec 2017
Expiry Date:

Last updated: 13 Dec 2018

Reference: 185719

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Today, metformin (Glucophage) is the most widely prescribed first oral medication for patients with type II diabetes (DM II). It is included in the World Health Organization's List of Essential Medicines and recommended as first and monotherapy by the American Diabetes Association in their updated (2017) position statement.

Objectives

TO PROMOTE A BETTER UNDERSTANDING OF METFORMIN AND HOW IT IMPACTS ON A PATIENTS DIAGNOSIS.

TO PROMOTE A BETTER UNDERSTANDING OF METFORMIN AND HOW IT IMPACTS ON A PATIENTS DIAGNOSIS.
Dr Nina Kriel

Author Information Play Video Bio

Dr Nina Kriel
on behalf of Synapse Optometry

Dr Nina Kriel

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error